Additionally, after oral administration of histidine, an increase in fasting plasma histidine concentration leads to various beneficial effects on glycemic control in T2D participants, including reduced fasting glucose, HbA1c, time in range, and average amplitude of glycemic excursions, as well as enhanced insulin sensitivity [36]. The gene discussed is INS; the disease is type 2 diabetes mellitus.